{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:46:20Z","timestamp":1794257180564,"version":"4.9.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jbspin.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T05:20:17Z","timestamp":1396416017000},"page":"421-425","source":"Crossref","is-referenced-by-count":50,"title":["Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study"],"prefix":"10.1016","volume":"81","author":[{"given":"Roberta","family":"Ramonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Puato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rattazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Balbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusta","family":"Ortolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Frallonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Faggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Zaninotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Lorenzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pauletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2014.02.005_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-7-25","article-title":"The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people","volume":"7","author":"Salaffi","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0010","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.rdc.2005.01.006","article-title":"Inflammation and accelerated atherosclerosis: basic mechanisms","volume":"31","author":"Doria","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0020","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0025","first-page":"298","article-title":"Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data","volume":"61","author":"Contessa","year":"2009","journal-title":"Reumatismo"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0030","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004872-200502000-00001","article-title":"Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension","volume":"23","author":"Brunner","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2310\/6650.2006.05051","article-title":"Atherosclerosis: immune and inflammatory aspects","volume":"54","author":"Reiss","year":"2006","journal-title":"J Invest Med"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0045","first-page":"1544","article-title":"Patterns of cytokine production in psoriatic synovium","volume":"25","author":"Ritchlin","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0050","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/HYPERTENSIONAHA.107.106773","article-title":"Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension","volume":"51","author":"Puato","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.22530","article-title":"Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0065","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.autrev.2011.05.022","article-title":"Atherosclerosis in psoriatic arthritis","volume":"10","author":"Ramonda","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.autrev.2006.12.003","article-title":"Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis","volume":"6","author":"Punzi","year":"2007","journal-title":"Autoimm Rev"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2011-200350","article-title":"European League Against Rheumatism. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies","volume":"71","author":"Gossec","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4081\/reumatismo.2012.59","article-title":"Psoriatic arthritis. When the heterogeneity requires normality","volume":"64","author":"Punzi","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0085","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000081812","article-title":"Mannheim intima-media thickness consensus","volume":"18","author":"Touboul","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004872-200501000-00004","article-title":"Endothelial function dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension","volume":"23","author":"Deanfield","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0100","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.CIR.74.6.1399","article-title":"Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging","volume":"74","author":"Pignoli","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1109\/TMI.2006.891477","article-title":"A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images","volume":"26","author":"Gemignani","year":"2007","journal-title":"IEEE Trans Med IM aging"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0110","article-title":"The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/ard.2010.131359","article-title":"Tumour necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis: a 2-year pilot study","volume":"70","author":"Tam","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0120","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/ATVBAHA.110.214585","article-title":"Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-alpha blockers and traditional disease-modifying antirheumatic drugs","volume":"31","author":"Di Minno","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11739-010-0458-6","article-title":"Anti-tumor necrosis factor-\u03b1 therapy and changes of flow-mediated vasodilation in psoriatic and rheumatoid arthritis patients","volume":"5","author":"Mazzoccoli","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0130","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1136\/ard.2009.127597","article-title":"Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study","volume":"69","author":"Jamnitski","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0135","article-title":"Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients","author":"Costa","year":"2013","journal-title":"ClinRheumatol"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cca.2011.10.019","article-title":"A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides","volume":"413","author":"Oliviero","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0145","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1196\/annals.1351.039","article-title":"Effects of anti-TNF-\u03b1 treatment on lipid profile in patients with active rheumatoid arthritis","volume":"1069","author":"Seriolo","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0150","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1684\/ejd.2011.1548","article-title":"Effects of etanercept treatment on lipid profile in patients with moderate-to-severe chronic plaque psoriasis: a retrospective cohort study","volume":"21","author":"Lestre","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0155","first-page":"469","article-title":"Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions","volume":"23","author":"Edrees","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0160","first-page":"2102","article-title":"Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis","volume":"32","author":"Macias","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0165","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s11596-012-1011-9","article-title":"TNF-\u03b1 induces endothelial dysfunction via PKC-\u03b6-dependent NADPH oxidase activation","volume":"32","author":"Huang","year":"2012","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/jhh.2013.62","article-title":"Impact of hypertension on subclinical atherosclerosis in patients with Psoriatic Arthritis","volume":"28","author":"Puato","year":"2014","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0175","article-title":"Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","author":"Rosales Alexander","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jbspin.2011.09.017","article-title":"TNF\u03b1: activator or inhibitor of regulatory T cells?","volume":"79","author":"Biton","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0185","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1538-7836.2010.03990.x","article-title":"Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromso Study","volume":"8","author":"Vik","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/ar2915","article-title":"CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis","volume":"12","author":"Chiu","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0195","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1538-7836.2012.04726.x","article-title":"Osteoprotegerin levels are increased in patients with venous thromboembolic disease","volume":"10","author":"Rattazzi","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jbspin.2014.02.005_bib0200","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1177\/1535370213506435","article-title":"Serological markers in psoriatic arthritis: promising tools","volume":"238","author":"Ramonda","year":"2013","journal-title":"Exp Biol Med (Maywood)"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14000499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14000499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T03:49:43Z","timestamp":1597636183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X14000499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1297319X14000499"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2014.02.005","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}